This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Orca Bio on Monday said its T cell therapy, when used in people with certain blo...
For the 162nd episode of the Healthcare IT Today Podcast, we are doing a little ...
Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Su...
The current wave of generative AI has captured public imagination, but we must t...
AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC...
At the end of Robert F. Kennedy Jr.'s confirmation hearing, Senate HELP Committe...
Steve Heard, Chief Innovation Officer at J2 Interactive, presents a strategy in ...
Modern trial designs, digital solutions and a deeper understanding of patient re...
Berry Street, the leading nutrition counseling platform in the US has raised $50...
GRO Biosciences, a small but ambitious biotech startup attempting to create nove...
A Seattle biotech trying to take on one of the world’s biggest vaccines has nabb...
A small Swiss drug developer is being scooped up for its pipeline of three antib...
AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC...
A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug develop...
Avidity Biosciences shared Monday that its RNA drug for people with certain muta...
AstraZeneca said Monday that it has agreed to acquire a cell therapy biotech fou...